Carpal Tunnel Release: Minor Procedure Room or Operating Room?

2021 ◽  
pp. 917-920
Author(s):  
Kevin Cheung ◽  
Hannah St Denis‐Katz
Author(s):  
Andrew R. Stephens ◽  
Andrew R. Tyser ◽  
Angela P. Presson ◽  
Brian Orleans ◽  
Angela A. Wang ◽  
...  

2013 ◽  
Vol 27 (4) ◽  
pp. 611-614 ◽  
Author(s):  
Edward R. Mariano ◽  
Megan K. Lehr ◽  
Vanessa J. Loland ◽  
Michael L. Bishop

2011 ◽  
Vol 114 (1) ◽  
pp. 240-244 ◽  
Author(s):  
Abdullah Nabhan ◽  
Wolf-Ingo Steudel ◽  
Lutfi Dedeman ◽  
Jehad Al-Khayat ◽  
Basem Ishak

Object This study compares the effectiveness of subcutaneous infiltration of a local anesthetic agent (LA) versus intravenous regional anesthesia (IVRA) during endoscopic carpal tunnel release. Methods Forty-four patients suffering from severe symptoms restricting normal daily activities—such as persistent loss of feeling in the fingers or hand, or no strength in the thumb in spite of prolonged nonsurgical treatment—and with electromyographically proven carpal tunnel syndrome were enrolled in this study. All underwent endoscopic carpal tunnel release. Twenty-two patients had an endoscopic release of the median nerve under LA (LA Group). The other 22 patients underwent the surgery after intravenous induction of regional anesthesia (IVRA Group). The operating room in-out time and tourniquet time were evaluated in both groups. The patients were also asked to evaluate the pain associated with the tourniquet during surgery using a visual analog scale. The Michigan Hand Outcomes Questionnaire was used to assess the functional outcome preoperatively and at both 2 weeks and 6 months postoperatively. Results One patient in the LA Group needed an additional application of prilocaine, whereas 3 patients in the IVRA Group needed additional LA and 1 of these required propofol. The tourniquet time and operating room time were significantly lower in the LA Group (p = 0.01 for both). There were no complications related to the endoscopic surgery. The Michigan Hand Outcomes Questionnaire did not show significant differences between the groups at either postoperative follow-up examination. Conclusions Endoscopic carpal tunnel release with subcutaneous infiltration of LA was well tolerated and effective. Injection-associated problems such as increased thickness of the synovial layer or impaired endoscopic view did not occur.


2021 ◽  
Vol 9 (7) ◽  
pp. e3685
Author(s):  
Dustin J. Randall ◽  
Kate Peacock ◽  
Katelin B. Nickel ◽  
Margaret Olsen ◽  
Andrew R. Tyser ◽  
...  

2014 ◽  
Vol 219 (4) ◽  
pp. e35
Author(s):  
Naveed Nosrati ◽  
Stephen P. Duquette ◽  
Adam C. Cohen ◽  
Rajiv Sood ◽  
Imtiaz A. Munshi ◽  
...  

2003 ◽  
Vol 8 (4) ◽  
pp. 4-5
Author(s):  
Christopher R. Brigham ◽  
James B. Talmage

Abstract Permanent impairment cannot be assessed until the patient is at maximum medical improvement (MMI), but the proper time to test following carpal tunnel release often is not clear. The AMA Guides to the Evaluation of Permanent Impairment (AMA Guides) states: “Factors affecting nerve recovery in compression lesions include nerve fiber pathology, level of injury, duration of injury, and status of end organs,” but age is not prognostic. The AMA Guides clarifies: “High axonotmesis lesions may take 1 to 2 years for maximum recovery, whereas even lesions at the wrist may take 6 to 9 months for maximal recovery of nerve function.” The authors review 3 studies that followed patients’ long-term recovery of hand function after open carpal tunnel release surgery and found that estimates of MMI ranged from 25 weeks to 24 months (for “significant improvement”) to 18 to 24 months. The authors suggest that if the early results of surgery suggest a patient's improvement in the activities of daily living (ADL) and an examination shows few or no symptoms, the result can be assessed early. If major symptoms and ADL problems persist, the examiner should wait at least 6 to 12 months, until symptoms appear to stop improving. A patient with carpal tunnel syndrome who declines a release can be rated for impairment, and, as appropriate, the physician may wish to make a written note of this in the medical evaluation report.


Sign in / Sign up

Export Citation Format

Share Document